Reply to: are transdermal opioids contraindicated in patients at risk of suicide?

However, on critical review of the case report, it is unclear whether the patient had been on a fentanyl patch or other opioid prior to her admission. If she had been opioid naı̈ve (this information is not available from the case report) at the time of her admission, starting her on a fentanyl patch would have been inappropriate, let alone the issue that the patient was admitted to the hospital ward related to a suicide attempt.

[1]  W. Ruppen,et al.  Are transdermal opioids contraindicated in patients at risk of suicide?: An underappreciated problem. , 2016, European journal of anaesthesiology.

[2]  A. Kaye,et al.  Prescription Opioid Duration of Action and the Risk of Unintentional Overdose. , 2015, JAMA internal medicine.

[3]  L. Mezei,et al.  Pain education in North American medical schools. , 2011, The journal of pain : official journal of the American Pain Society.

[4]  M. Cheatle Depression, chronic pain, and suicide by overdose: on the edge. , 2011, Pain medicine (Malden, Mass.).

[5]  R. Palmer Fentanyl in postmortem forensic toxicology , 2010, Clinical toxicology.

[6]  A. Rabavilas,et al.  Oral Transmucosal Abuse of Transdermal Fentanyl , 2004, Journal of psychopharmacology.

[7]  D. Dongelmans,et al.  Inefficacy of high‐dose transdermal fentanyl in a patient with neuropathic pain a case report , 2001, European journal of pain.

[8]  A. Kaye,et al.  Are transdermal opioids contraindicated in patients at risk of suicide? , 2017, European journal of anaesthesiology.

[9]  J. Pinto-Gouveia,et al.  Psychological distress, burnout and personality traits in Dutch anaesthesiologists. , 2017, European journal of anaesthesiology.